T. Rowe Price Investment Management, Inc.
Position in IMTX — Immatics N.V.
CIK 1897612
BALTIMORE, MD
Position in IMTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$213,057,274
-$12,263,864 QoQ
Shares Held
21,652,162
+0.9% QoQ
Ownership
15.8%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 99.76322918699758.ToString("F0")%
Shared 0.ToString("F0")%
None 0.23677081300241518.ToString("F0")%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. IMTX ranks #14 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,193,324 | $1,718,315,111 | |
| 2 | ASND |
Ascendis Pharma A/S
|
6,162,042 | $1,409,443,866 | |
| 3 | CYTK |
Cytokinetics Inc
|
17,523,840 | $1,154,996,294 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
10,300,984 | $867,033,823 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,126,017 | $704,642,847 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,785,801 | $558,146,572 | |
| 7 | BNTX |
BioNTech SE
|
5,856,073 | $520,487,768 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
6,159,027 | $462,481,337 |
All Filings in IMTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $213,057,274 | 21,652,162 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $225,321,138 | 21,459,156 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $165,144,599 | 19,383,169 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $98,607,087 | 18,328,455 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $66,193,283 | 14,677,003 | Shares | Sole | 2025-05-14 | |
| 2025-02-28 | $61,988,204 | 14,152,558 | Shares | Sole | 2025-03-07 | |
| 2024-12-31 | $75,399,964 | 10,604,777 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $84,201,646 | 7,379,636 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $86,379,675 | 7,433,707 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $66,262,102 | 6,304,672 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,738,499 | 2,824,169 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,833,080 | 2,230,836 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,539,347 | 2,213,115 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||